Minahasa Membangun Hebat Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Minahasa Membangun Hebat Tbk. trades at Rp272 (market cap 285.16B, 4.43M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 39.2× Minahasa Membangun Hebat Tbk.'s market cap, and Minahasa Membangun Hebat Tbk. is more actively traded (4.43M versus 613K). Which is the better fit depends on your goals.
| HBAT | TSPC | |
|---|---|---|
Market Cap | 285.16B | 11.18T |
Volume | 4.43M | 613K |
Lot | 44.33K | 6.13K |
Turnover | 1.17B | 1.54B |
Average Price | 264.91 | 2,511.52 |
Value | 1.17B | 1.54B |
Indicative Equilibrium Price | 272 | 2,520 |
Indicative Equilibrium Volume | 22 | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Minahasa Membangun Hebat Tbk was established based on Notarial Deed No. 44 datedJanuary 31, 2020 of Dian Fitriana, S.H., M.Kn., a public notary in Bekasi.
Read more on HBAT →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →